Mirae Asset Global Investments Co., Ltd. - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$7,521,009
-15.2%
210,968
+9.8%
0.02%
-10.5%
Q2 2023$8,865,510
-5.2%
192,123
-17.6%
0.02%
-13.6%
Q1 2023$9,349,556
-10.2%
233,156
+3.8%
0.02%
-18.5%
Q4 2022$10,409,285
+89.7%
224,677
+69.6%
0.03%
+80.0%
Q3 2022$5,487,000
-28.2%
132,492
+3.4%
0.02%
-21.1%
Q2 2022$7,645,000
-61.6%
128,159
-53.2%
0.02%
-9.5%
Q1 2022$19,884,000
+47.1%
273,812
+70.4%
0.02%
-27.6%
Q4 2021$13,515,000
+21.4%
160,727
+30.2%
0.03%
+3.6%
Q3 2021$11,131,000
+14.0%
123,407
+20.5%
0.03%
+3.7%
Q2 2021$9,764,000
-2.8%
102,395
+16.0%
0.03%
-22.9%
Q1 2021$10,049,000
+33.0%
88,261
+61.7%
0.04%
+25.0%
Q4 2020$7,558,000
+107.4%
54,598
+23.1%
0.03%
+55.6%
Q3 2020$3,644,000
+47.2%
44,336
+40.1%
0.02%
+20.0%
Q2 2020$2,476,000
+162.6%
31,645
+49.0%
0.02%
+114.3%
Q1 2020$943,000
+16.3%
21,242
+11.8%
0.01%
+40.0%
Q4 2019$811,000
+75.2%
18,994
+75.7%
0.01%
+66.7%
Q3 2019$463,000
+92.1%
10,809
+185.4%
0.00%
+50.0%
Q2 2019$241,0003,7870.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders